BioHealth News Archive
MedImmune, AbPro collaborate to develop novel bispecific antibody
MedImmune, a global biologics research and development arm of AstraZeneca, and Abpro, an integrated life sciences company at the forefront of synthetic biology, announced…
Read MoreTufts and Johns Hopkins win $25 million NIH award to build new trial innovation center | EurekAlert! Science News
Investigators at the Institute for Clinical Research and Health Policy Studies (ICRHPS) at Tufts Medical Center (Tufts MC) and Tufts Clinical and Translational Science…
Read MoreWhither the CMS Innovation Center under Trump? – MedCity News
Joint replacements. Cardiac care. Chemotherapy. What do those things have to do with the repeal of the Affordable Care Act? Economists and policymakers think…
Read MoreFive-year reauthorization of SBIR/STTR gains – New Hampshire Business Review – December 9 2016
A five-year extension of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs took a big step forward at the…
Read MoreMarriott Hotels Launches Its Own Tech Startup Accelerator
Marriott Hotels in Europe has launched an accelerator program for tech companies to enhance the travel and hospitality experience. Each startup will be given expert…
Read MoreThermo Fisher buys MTI-GlobalStem upping stem cell and media offering
Thermo Fisher has bolstered its stem cell technology and reagent business through the acquisition of MTI-GlobalStem. {iframe}http://www.biopharma-reporter.com/Bio-Developments/Thermo-Fisher-buys-MTI-GlobalStem-upping-stem-cell-and-media-offering{/iframe}
Read MoreAstraZeneca, Bicycle Launch $1B+ Bicyclic Peptide Collaboration – GEN
AstraZeneca will partner with Bicycle Therapeutics to develop respiratory, cardiovascular, and metabolic disease treatments based on Bicycle’s proprietary bicyclic peptide (Bicycle®) product platform through…
Read MoreThe next act in healthcare private equity – McKinsey & Company
Buyout firms have taken an increasingly large role in healthcare, investing in the full range of companies: insurers, hospitals, pharmaceutical companies, medical-technology firms, and…
Read MoreNOT-HL-16-472: Request for Information (RFI): NHLBI Translational Research
This request for information (RFI) seeks comments regarding early translational research activities supported by NHLBI. Background NHLBI seeks to facilitate and accelerate the development…
Read MoreVideo: Merck selects Alexandria Real Estate to develop research facility
Alexandria Real Estate CEO Joel Marcus on the company's deal to develop Merck's new research facility in California. {iframe}http://www.msn.com/en-us/money/watch/merck-selects-alexandria-real-estate-to-develop-research-facility/vi-AAkXjoR{/iframe}
Read MoreFACT SHEET: Celebrating President Obama’s Top 10 Actions to Advance Entrepreneurship, and Announcing New Steps to Build on These Successes | whitehouse.gov
America’s entrepreneurial economy is the envy of the world. Young companies account for almost 30 percent of new jobs, and as we have fought…
Read MoreMedImmune, Abpro to Develop Bispecific Antibody – GEN
MedImmune and Abpro said today they will partner to develop a preclinical, novel, bispecific antibody targeting angiopoietin-2 and vascular endothelial growth factor (Ang2-VEGF). Through…
Read MoreThe Promise and Challenge of Big Data for Pharma
The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel…
Read MoreCoapTech, LLC, And University of Maryland, Baltimore Set Stage To Commercialize Novel Procedure For
University of Maryland (UM) Ventures and CoapTech, LLC, announced today that the University of Maryland, Baltimore (UMB) has granted CoapTech exclusive licensing rights for…
Read MoreStephen Moret leaving LSU Foundation for economic development job in Virginia
Stephen Moret, the head of LSU's major fundraising arm and a former key adviser to then-Gov. Bobby Jindal, is leaving Louisiana for Virginia. Moret…
Read More